Long Island TS Clinical Trials
Please note the following information regarding important clinical trials being conducted at North Shore Hospital in Manhasset under Cathy Budman, MD, that we would like to bring to the attention of the Long Island TS Community.
Genetics of Tourette Syndrome:
This is a study co-funded by the National Institute of Health/NINDS and the National Tourette Syndrome Association, performed by members of the International TS Genetics Consortium. North Shore Hospital in Manhasset serves as the regional participating site for this study that is being conducted world-wide. We are seeking all persons, both adults and/or children with TS to participate in this genetic study which is trying to identify important genes and genetic mechanisms in TS and its related disorders. Participation is a one-time event that entails completing a questionnaire about clinical symptoms and history and providing a single blood sample that will be sent for analysis.
Pramipexole Treatment of TS in children ages 6-17 years
This is a Phase II clinical trial investigating a potential new medication for treating tics in children. It is a 6-week study studying the safety and efficacy of the medication pramipexole in children with TS. Enrollment will close in early January 2009 so interested families should contact Dr. Budman immediately if they would like to obtain additional information and/or possibly set up screening for participation.
It is essential that we learn more about TS and its treatment so that we can improve the lives of people who suffer from this disorder. Any individuals who may be interested in participating in either or both of these studies should contact Dr. Budman or her Clinical Study Coordinator Michelle Lubomski immediately.
Interested individuals can contact Michelle Lubomski at 516-562-3224 or by email at mlubomski@nshs.com, or can call Dr. Budman at: 516 562-3223.